Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder

This observational study (n=22) analysed audio transcripts from a 12-week trial of 25 mg COMP360 psilocybin for post-traumatic stress disorder to examine how much participants and support providers spoke during sessions. It found that administration sessions were mostly silent, with reassurance and validation being the main forms of support.